Life Science Investing Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
Life Science Investing Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
Nextech3D.ai Reports Strong 20% Q2 Sequential Revenue Growth With Gross Margins of 88% For the Three Months Ended September 30, 2025 ("Q2 2026")
Troy Minerals Updates on the Operational Mining Permit for its Tsagaan Zalaa Silica Project, Mongolia and Initiates Commodity Off-Take Discussions
NextSource Materials Announces Upsizing of Funding Facility from Vision Blue Resources to Advance UAE Anode Facility Development
